Global Clinical Lead, Specialty Medicine

Daiichi Sankyo, Inc.; Basking Ridge (NJ); On-site; USD 329,000 - 548,000; Full time

Job summary

Daiichi Sankyo, Inc. in New Jersey seeks an experienced Global Clinical Lead for non-oncology Specialty Medicine within Early Development Oncology.

The role spans immunology, ophthalmology, cardiovascular disease, and emerging areas, combining broad early-development expertise with end-to-end global development judgment from preclinical through Phase 3. The position replaces a vacant director-level role and requires independent decision-making, global collaboration, and leadership across

Qualifications

• MD is required and postgraduate training in a non-oncology therapeutic area or related specialty is required.
• Global clinical development experience spanning preclinical through Phase 3 with senior-level accountability is expected.
• Experience leading cross-functional study design, execution, and interpretation with a focus on patient safety and data quality.
• Ability to lead external collaborations, engage with regulators, and represent the program in governance forums.

Responsibilities

• Lead end-to-end global clinical development for assigned non-oncology programs from preclinical to Phase 3.
• Provide medical accountability and oversight for clinical trials, including data reviews and safety assessments.
• Direct cross-functional study design, feasibility, execution, and interpretation while ensuring compliance.
• Represent clinical development in regulatory, governance, and external forums; guide due diligence of external opportunities.
• Lead the internal and external clinical network and strengthen development capabilities.

Education

MD

Postgraduate training in non-oncology therapeutic area

Tools

Microsoft Word

Excel

PowerPoint

Electronic Data Capture (e.g., RAVE)

J-Review

Job description

Daiichi Sankyo, Inc. in New Jersey seeks an experienced Global Clinical Lead for non-oncology Specialty Medicine within Early Development Oncology.

The role spans immunology, ophthalmology, cardiovascular disease, and emerging areas, combining broad early-development expertise with end-to-end global development judgment from preclinical through Phase 3. The position replaces a vacant director-level role and requires independent decision-making, global collaboration, and leadership across